ARTICLE | Company News
Genzyme Molecular, Imgenex Corp. deal
February 12, 2001 8:00 AM UTC
Imgenex will produce monoclonal antibodies as research reagents against a number of angiogenesis protein targets provided by GZMO. GZMO will have rights to use antibodies produced for research, and wi...